St. John's Wort Extract LI 160 for the Treatment of Atypical Depression
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The aim of tis study is to assess the efficacy and safety of Jarsin® 300 mg as an acute
treatment in mild to moderate depression with atypical features.